Anagnost Andrew

Officer, Director at ADSK

Sold, on record
$58.4M
Dollars the filings state
Form 4 sales
19
Latest Mar 27, 2024
Form 144 notices
2
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • ADSKAutodesk, Inc.Officer, Director

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale ADSKUnusual
    Sep 2 2021

    Sold 2,434 shares at $286.18 ($697k)

    Anagnost Andrew, President and CEO

    Sold 100% of holdings ($697k position)0 shares left0.1x usual sizeFiling

  2. 2 Form 4 sale ADSKUnusual
    Dec 3 +92 days

    Sold 4,724 shares at $256.27 ($1.2M)

    Anagnost Andrew, President and CEO

    Sold 100% of holdings ($1.2M position)0 shares left0.2x usual sizeFiling

  3. 3 Form 4 sale ADSKUnusual
    Aug 29 +269 days

    Sold 34,366 shares at $206.87 ($7.1M)

    Anagnost Andrew, President and CEO

    Sold 30.9% of holdings ($23M position)76,968 shares left2.4x usual sizeFiling

  4. 4 Form 4 sale ADSKRoutine
    Mar 28 +211 days

    Sold 2,847 shares at $196.75 ($560k)

    Anagnost Andrew, President and CEO

    10b5-1 planSold 3.2% of holdings ($17.4M position)85,452 shares left0.2x usual sizeFiling

  5. 5 Form 144 notice ADSKNotice
    Sep 1 +157 days

    Filed to sell 22,318 shares ($5M)

    Anagnost Andrew, Officer, Director

    10b5-1 plan5.9x usual sizeFiling

  6. 6 Form 4 sale ADSKUnusual
    Sep 1 same day

    Sold 22,318 shares at $221.90 ($5M)

    Anagnost Andrew, President and CEO

    10b5-1 planSold 18.3% of holdings ($27M position)99,327 shares left5.9x usual sizeFollows a Form 144Filing

  7. 7 Form 144 notice ADSKNotice
    Mar 27 +208 days

    Filed to sell 21,053 shares ($5.5M)

    Anagnost Andrew, Officer, Director

    10b5-1 plan0.9x usual sizeFiling

  8. 8 Form 4 sale ADSKRoutine
    Mar 27 same day

    Sold 21,053 shares at $259.99 ($5.5M)

    Anagnost Andrew, President and CEO

    10b5-1 planSold 16.7% of holdings ($32.8M position)105,213 shares left0.9x usual sizeFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (21)

Form 144 notices and Form 4 sales by Anagnost Andrew
Source
Mar 27, 2024ADSKPresident and CEOForm 4 sale21,053$5.5M16.7%RoutineSEC
Mar 27, 2024ADSKOfficer, DirectorForm 144 notice21,053$5.5MNoticeSEC
Sep 1, 2023ADSKPresident and CEOForm 4 sale22,318$5M18.3%UnusualSEC
Sep 1, 2023ADSKOfficer, DirectorForm 144 notice22,318$5MNoticeSEC
Mar 28, 2023ADSKPresident and CEOForm 4 sale2,847$560k3.2%RoutineSEC
Aug 29, 2022ADSKPresident and CEOForm 4 sale34,366$7.1M30.9%UnusualSEC
Dec 3, 2021ADSKPresident and CEOForm 4 sale4,724$1.2M100.0%UnusualSEC
Sep 2, 2021ADSKPresident and CEOForm 4 sale2,434$697k100.0%UnusualSEC
Aug 26, 2021ADSKPresident and CEOForm 4 sale23,957$7.6M26.2%UnusualSEC
Mar 26, 2021ADSKPresident and CEOForm 4 sale43,735$11.5M94.7%UnusualSEC
Jun 19, 2020ADSKPresident and CEOForm 4 sale22,639$5.5M16.6%Plan not statedSEC
Jun 20, 2019ADSKPresident and CEOForm 4 sale2,434$413k2.8%Plan not statedSEC
Mar 29, 2019ADSKPresident and CEOForm 4 sale10,023$1.6M9.9%Plan not statedSEC
Mar 15, 2019ADSKPresident and CEOForm 4 sale10,440$1.6M14.2%Plan not statedSEC
Oct 5, 2018ADSKPresident and CEOForm 4 sale23,008$3.5M22.2%UnusualSEC
Mar 29, 2018ADSKPresident and CEOForm 4 sale20,499$2.6M13.9%UnusualSEC
Aug 28, 2017ADSKPresident and CEOForm 4 sale24,004$2.7M16.6%UnusualSEC
Mar 29, 2017ADSKCo-CEO & CMOForm 4 sale3,954$337k2.8%Plan not statedSEC
Mar 13, 2017ADSKCo-CEO & CMOForm 4 sale5,540$476k4.7%Plan not statedSEC
Nov 10, 2016ADSKSVP, ISMForm 4 sale4,525$339k4.0%Plan not statedSEC
Sep 21, 2016ADSKSVP, ISMForm 4 sale4,525$317k3.9%Plan not statedSEC